APAC Dermal Fillers Market

APAC Dermal Fillers Market Size (2023 to 2028)

The Dermal Fillers Market in the Asia Pacific is anticipated to be worth USD 2.72 billion by 2028 from USD 1.80 in 2023, growing at the fastest CAGR of 8.61% during the forecast period.

The growing influence majorly drives the Asia Pacific dermal fillers market. the women of middle age in enhancing their physical appearance and beauty awareness, which is likely to fuel Asia Pacific dermal fillers market growth over the forecast period. Increasing discretionary income and rising familiarity of non-invasive about non-invasive cosmetic treatments foster dermal fillers' growth in this region. It is multiplying research and development activities by many key players in manufacturing dermal fillers in the area.

Side effects associated with dermal fillers treatment, such as itching, redness, and bruising, which harm the skin, are major factors impeding the market. In addition, high costs associated with dermal fillers and an increasing number of unlicensed practitioners, resulting in several faulty surgical methods, are further expected to stand as an obstacle to APAC dermal fillers market growth.

This research report on the APAC dermal fillers market has been segmented & sub-segmented into the following categories:

By Product: 

• Absorbable or Biodegradable
• Non-Absorbable or Non-Biodegradable

By Therapeutic Area: 

• Wrinkles
• Deep Facial Lines
• Sagging Skin
• Scars

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Based on geography, the developing nations in the Asia Pacific hold considerable potential for growth in the dermal filler market due to its quick and accurate results without any risk to the skin. The dermal fillers market in Asia-Pacific is estimated to grow with the highest CAGR of 8.61 during the forecast period due to the appearance of an enormous consumer base, essential advancements in medical infrastructure, and rapid economic development. Moreover, the rising elder people population augmenting demand for facial aesthetics products which boosts the growth. Countries like China, India, and Japan are the major contributors to the APAC region.

The Chinese dermal fillers market is expected to lead the market. It is the most significant contributor to the growth of the dermal fillers market. There are tremendous opportunities with growing discretionary income, a rising number of dermatological consultations, skincare clinics, and increasing demand for skin specialists. As a result, China is expected to grow with the highest CAGR of 8.7% over the analysis period. The key factor responsible for the market's growth is the economy, which is becoming research and development, influence over average income integrated with changes made in consumer habits in the Chinese population.

The Indian dermal fillers market is estimated to grow with a CAGR of 8.9% over the forecast period, increasing awareness in developed and existing economies regarding the region's cosmetic procedures. As a result, the pharmaceutical companies in this country have been growing inevitably as a capability to acquire advanced cosmetic procedures. Moreover, the growth is captured due to favorable demographics, socio-economic changes, and urbanization amidst motionless lifestyles.

KEY MARKET PLAYERS:

A few major companies operating in the APAC dermal fillers market profiled in this report are Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron, and Cytophil Inc.